Active ingredientCiprofibrateCat. No. P-C172-001CAS 52214-84-3Family · Pharmaceutical analytical standards
Ciprofibrate
A lipid-lowering fibrate, patented in 1972 and approved for medical use in 1985, used to lower blood fats, especially triglycerides. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?Compared with the older clofibrate, instead of a single chlorine atom on the benzene ring it carries a small cyclopropane ring bearing two chlorine atoms; it is used as a mixture of its two mirror-image forms.
Go to the active ingredient →Active ingredientCiprofibrateCat. No. P-C172-001CAS 52214-84-3
Pharmacopoeial impurityCiprofibrate EP Impurity ACat. No. P-C172-002CAS 1474058-89-3
Pharmacopoeial impurityCiprofibrate EP Impurity BCat. No. P-C172-003CAS 52179-26-7
Pharmacopoeial impurityCiprofibrate EP Impurity CCat. No. P-C172-004CAS 2469279-29-4
Pharmacopoeial impurityCiprofibrate EP Impurity DCat. No. P-C172-005CAS 130232-51-8
Pharmacopoeial impurityCiprofibrate EP Impurity ECat. No. P-C172-006CAS 52179-28-9
MetaboliteCiprofibrate-O-beta-D-GlucuronideCat. No. P-C172-007CAS 102623-15-4
Isotopically labelledCiprofibrate-d6Cat. No. P-C172-008CAS 2070015-05-1
ImpurityAcetyl CiprofibrateCat. No. P-C172-009CAS 144900-34-5No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceCiprofibrate CRSEDQM code Y0000362Family CiprofibrateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.